Huffman Lynn C, Koch Sheryl E, Butler Karyn L
Department of Surgery, Division of Trauma/Critical Care, Institute of Molecular Pharmacology and Biophysics, University of Cincinnati, 231 Albert B. Sabin Way, Cincinnati, OH 45267-0828, USA.
Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H257-62. doi: 10.1152/ajpheart.00769.2007. Epub 2007 Nov 2.
Preconditioning (PC) protects against ischemia-reperfusion (I/R) injury via the activation of the JAK-STAT pathway. We hypothesized that the mediators responsible for PC can be transferred to naive myocardium through the coronary effluent. Langendorff-perfused hearts from male Sprague-Dawley rats were randomized to paired donor/acceptor protocols with or without PC in the presence or absence of the JAK-2 inhibitor AG-490 (n = 6 for each group). Warmed, oxygenated coronary effluent collected during the reperfusion phases of PC (3 cycles of 5 min ischemia and 5 min reperfusion) was administered to acceptor hearts. The hearts were then subjected to 30 min ischemia and 40 min reperfusion. The left ventricles were analyzed for phosphorylated (p)STAT-1, pSTAT-3, Bax, Bcl, Bcl-X(L)/Bcl-2-associated protein (BAD), and caspase-3 expression by Western blot. A separate group of hearts (n = 6) was analyzed for STAT activation immediately after the transfer of the PC effluent (no I-R). Baseline cardiodynamics were not different among the groups. End-reperfusion maximal change in pressure over time (+dP/dt(max)) was significantly (P < 0.05) improved in acceptor PC (3,637 +/- 199 mmHg/s) and donor PC (4,304 +/- 347 mmHg/s) hearts over non-PC donor (2,020 +/- 363 mmHg/s) and acceptor (2,624 +/- 345 mmHg/s) hearts. Similar differences were seen for minimal change in pressure over time (-dP/dt(min)). STAT-3 activation was significantly increased in donor and acceptor PC hearts compared with non-PC hearts. Conversely, pSTAT-1 and Bax expression was decreased in donor and acceptor PC hearts compared with non-PC hearts. No differences in Bcl, BAD, or caspase-3 expression were observed. Treatment with AG-490 attenuated the recovery of +/-dP/dt in acceptor PC hearts and significantly reduced pSTAT-3 expression. The PC coronary effluent activates JAK-STAT signaling, limits apoptosis, and protects myocardial performance from I/R injury.
预处理(PC)通过激活JAK-STAT信号通路来保护心肌免受缺血再灌注(I/R)损伤。我们推测,负责预处理的介质可通过冠状动脉流出液转移至未处理的心肌。将雄性Sprague-Dawley大鼠的Langendorff灌注心脏随机分为配对的供体/受体组,在有或无JAK-2抑制剂AG-490的情况下进行或不进行预处理(每组n = 6)。在预处理的再灌注阶段(5分钟缺血和5分钟再灌注的3个周期)收集温热、充氧的冠状动脉流出液,并注入受体心脏。然后使心脏经历30分钟缺血和40分钟再灌注。通过蛋白质免疫印迹法分析左心室中磷酸化(p)STAT-1、pSTAT-3、Bax、Bcl、Bcl-X(L)/Bcl-2相关蛋白(BAD)和半胱天冬酶-3的表达。在转移预处理流出液后(无I/R),立即对另一组心脏(n = 6)进行STAT激活分析。各组之间的基线心脏动力学无差异。与未预处理的供体(2,020 +/- 363 mmHg/s)和受体(2,624 +/- 345 mmHg/s)心脏相比,预处理受体(3,637 +/- 199 mmHg/s)和预处理供体(4,304 +/- 347 mmHg/s)心脏在再灌注结束时压力随时间的最大变化(+dP/dt(max))显著改善(P < 0.05)。压力随时间的最小变化(-dP/dt(min))也有类似差异。与未预处理的心脏相比,预处理供体和受体心脏中的STAT-3激活显著增加。相反,与未预处理的心脏相比,预处理供体和受体心脏中的pSTAT-1和Bax表达降低。未观察到Bcl、BAD或半胱天冬酶-3表达的差异。用AG-490处理可减弱预处理受体心脏中+/-dP/dt的恢复,并显著降低pSTAT-3表达。预处理冠状动脉流出液可激活JAK-STAT信号,限制细胞凋亡,并保护心肌功能免受I/R损伤。